- beauty
- pharma
Ginsenoside compound k
CAS 39262-14-1
Also registered as 2 other CAS numbers
79104-63-5 · 852637-00-4
Concern score
Ginsenoside compound k in plain language
Also known as Ginsenoside K · ginsenoside C-K · 20(S)-Ginsenoside CK · 20(S)-PROTOPANAXADIOL 20-O-.BETA.-D-GLUCOPYRANOSIDE · 20-O-β-Glucopyranosyl-20(S)-protopanaxadiol · 3-O-DEGLUCOSYLGINSENOSIDE F2
Show all 18 names
Ginsenoside M1 · NT3 van SC6 · Protopanaxadiol 20-O-glucoside · 20(S)-Ginsenoside C-K · 20-O-.BETA.-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL · 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol · Compound CK · CompoundK · GM1 saponin · Ginsenoside compound K; Ginsenoside K · IH901 cpd · ginsenoside CK
Used in cosmetics as a skin-conditioning agent, a hair conditioner and a skin protectant. Ginsenoside Compound K is the saponin isolated from the roots of Panax ginseng.
- Skin conditioning
- Hair conditioning
- Skin protecting
- We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.
What we know about this ingredient
EPA DSSTox provides the canonical identifier, structure, and synonym profile for this chemical.
Regulation
No restrictions found. Ginsenoside compound k appears in these published regulatory listings.
- In marketed US drugs
EUCosIngActiveGinsenoside Compound K is the saponin isolated from the roots of Panax ginseng that conforms to the formula
- Ginsenoside Compound K is the saponin isolated from the roots of Panax ginseng that conforms to the formulaSource →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 2 active drug products and 2 total products.
- FDA NDC lists this ingredient in 2 active drug products and 2 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Expert safety opinions
No expert opinion on file for Ginsenoside compound k. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.
SCCS
EU Scientific Committee on Consumer Safety
No SCCS opinion on file.
CIR
Cosmetic Ingredient Review (US expert panel)
No CIR safety assessment on file.
Evidence & sources
No graded research studies for Ginsenoside compound k yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Where this comes from
- Open →
CosIng
regulatory · updated 2026-09-23
- Open →
EPA DSSTox Identifiers
chemistry · updated 2025-12-29
- Open →
FDA National Drug Code Directory
regulatory · updated 2026-12-31
- Open →
FDA GSRS UNII
registry · updated 2026-02-26
- Open →
openFDA Substance
registry · updated 2026-05-24
- Open →
PubChem Live Enrichment
chemistry · updated 2026-05-17
Reference links (1)
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
Where it has been recorded
How often FDA National Drug Code directory has listed Ginsenoside compound k in a product composition. These are source records, not Greenveil catalog products.
Source records
2
Typical roles